Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Wafer Works Shanghai (688584 CH)
Watchlist
18
Analysis
Information Technology
•
China
Wafer Works (Shanghai) Co.,Ltd. manufactures semiconductor devices. The Company produces and sells semiconductor epitaxial wafers, polishing sheets, and more. Wafer Works (Shanghai) markets its products worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Nationz Technologies Inc A
•
21 May 2025 07:28
CSI All Share Semiconductor Index Rebalance Preview: 13 Potential Changes in June
There could be 4 adds/9 deletes in June. Estimated turnover is 2.7% and round-trip trade is CNY 1.2bn. There are multiple stocks with same-way flow...
Brian Freitas
Follow
830 Views
Share
bullish
•
Bestechnic Shanghai
•
13 May 2025 06:30
STAR50/STAR100 Index Rebalance Preview: Strong Outperformance for STAR50 Changes
There could be 1/4 changes for the STAR50/100 indices. Estimated net round-trip trade is US$1.1bn. There are multiple stocks that will have same...
Brian Freitas
Follow
850 Views
Share
bullish
•
Suzhou Kematek
•
21 Apr 2025 07:41
CSI All Share Semiconductor Index Rebalance Preview: Multiple Index Flows for Some Stocks
There could be 12-13 changes for the index in June. Some stocks will have same way flows from multiple index trackers and those stocks could...
Brian Freitas
Follow
819 Views
Share
bullish
•
Bestechnic Shanghai
•
09 Apr 2025 05:58
STAR50/STAR100 Index Rebalance Preview: Central Huijin's ETF Creations Skew Performance
There could be 1/4 changes for the STAR50/STAR100 indices. Round-trip trade is over US$1bn. The deletes have outperformed the adds as Central...
Brian Freitas
Follow
824 Views
Share
bullish
•
Xiamen Amoytop Biotech Co Ltd
•
03 Mar 2025 05:30
STAR50/STAR100 Index Rebalance: Methodology Changes & Some Surprises
There are 3/6 changes for the STAR50/100 indices. Methodology changes result in a few surprises. The STAR50 adds/deletes have performed in line,...
Brian Freitas
Follow
1.1k Views
Share
First
Previous
1
2
3
4
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x